 | • レポートコード：QY2108PAL1114 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はドロキシドパの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ドロキシドパの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（ドロキシドパ錠、ドロキシドパカプセル、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ドロキシドパの世界市場概要 ・メーカー別の競争状況、市場シェア ・ドロキシドパの種類別市場規模：純度≥98％、純度<98％ ・ドロキシドパの用途別市場規模：ドロキシドパ錠、ドロキシドパカプセル、その他 ・北米のドロキシドパ市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのドロキシドパ市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのドロキシドパ市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のドロキシドパ市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのドロキシドパ市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Piramal Enterprises Limited、Lupin Ltd、Sun Pharmaceutical Industries Ltd.、Clarochem Ireland、Estechpharma Co., Ltd.、Chongqing Shenghuaxi Pharm Co.,Ltd.、JINLAN Pharm-Drugs Technology Co., Ltd. ・ドロキシドパのバリューチェーン・販売チャネル分析 ・ドロキシドパの世界市場動向 |
Droxidopa is a prodrug of norepinephrine used to increase the concentrations of these neurotransmitters in the body and brain. It is metabolized by aromatic L-amino acid decarboxylase (AAAD), also known as DOPA decarboxylase (DDC). Patients with NOH have depleted levels of norepinephrine which leads to decreased blood pressure or hypotension upon orthostatic challenge.[6] Droxidopa works by increasing the levels of norepinephrine in the peripheral nervous system (PNS), thus enabling the body to maintain blood flow upon and while standing. Droxidopa can also cross the blood–brain barrier (BBB) where it is converted to norepinephrine from within the brain. Increased levels of norepinephrine in the central nervous system (CNS) may be beneficial to patients in a wide range of indications. Droxidopa can be coupled with a peripheral aromatic L-amino acid decarboxylase inhibitor (AAADI) or DOPA decarboxylase inhibitor (DDC) such as carbidopa (Lodosyn) to increase central norepinephrine concentrations while minimizing increases of peripheral levels.
Market Analysis and Insights: Global Droxidopa Market
The global Droxidopa market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Droxidopa Scope and Segment
Droxidopa market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Droxidopa market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Droxidopa Tablets
Droxidopa Capsules
Others
By Company
Piramal Enterprises Limited
Lupin Ltd
Sun Pharmaceutical Industries Ltd.
Clarochem Ireland
Estechpharma Co., Ltd.
Chongqing Shenghuaxi Pharm Co.,Ltd.
JINLAN Pharm-Drugs Technology Co., Ltd.
Production by Region
Europe
China
India
South Korea
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Droxidopa Product Introduction
1.2 Market by Type
1.2.1 Global Droxidopa Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Market by Application
1.3.1 Global Droxidopa Market Size Growth Rate by Application
1.3.2 Droxidopa Tablets
1.3.3 Droxidopa Capsules
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Droxidopa Production
2.1 Global Droxidopa Production Capacity (2016-2027)
2.2 Global Droxidopa Production by Region: 2016 VS 2021 VS 2027
2.3 Global Droxidopa Production by Region
2.3.1 Global Droxidopa Historic Production by Region (2016-2021)
2.3.2 Global Droxidopa Forecasted Production by Region (2022-2027)
2.4 Europe
2.5 China
2.6 India
2.7 South Korea
3 Global Droxidopa Sales in Volume & Value Estimates and Forecasts
3.1 Global Droxidopa Sales Estimates and Forecasts 2016-2027
3.2 Global Droxidopa Revenue Estimates and Forecasts 2016-2027
3.3 Global Droxidopa Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Droxidopa Regions by Sales
3.4.1 Global Top Droxidopa Regions by Sales (2016-2021)
3.4.2 Global Top Droxidopa Regions by Sales (2022-2027)
3.5 Global Top Droxidopa Regions by Revenue
3.5.1 Global Top Droxidopa Regions by Revenue (2016-2021)
3.5.2 Global Top Droxidopa Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Droxidopa Production Capacity by Manufacturers
4.2 Global Droxidopa Sales by Manufacturers
4.2.1 Global Top Droxidopa Manufacturers by Sales (2016-2021)
4.2.2 Global Top Droxidopa Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Droxidopa Sales in 2020
4.3 Global Droxidopa Revenue by Manufacturers
4.3.1 Global Top Droxidopa Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Droxidopa Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Droxidopa Revenue in 2020
4.4 Global Droxidopa Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Droxidopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Droxidopa Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Droxidopa Sales by Type
5.1.1 Global Droxidopa Historical Sales by Type (2016-2021)
5.1.2 Global Droxidopa Forecasted Sales by Type (2022-2027)
5.1.3 Global Droxidopa Sales Market Share by Type (2016-2027)
5.2 Global Droxidopa Revenue by Type
5.2.1 Global Droxidopa Historical Revenue by Type (2016-2021)
5.2.2 Global Droxidopa Forecasted Revenue by Type (2022-2027)
5.2.3 Global Droxidopa Revenue Market Share by Type (2016-2027)
5.3 Global Droxidopa Price by Type
5.3.1 Global Droxidopa Price by Type (2016-2021)
5.3.2 Global Droxidopa Price Forecast by Type (2022-2027)
6 Market Size by Application
6.1 Global Droxidopa Sales by Application
6.1.1 Global Droxidopa Historical Sales by Application (2016-2021)
6.1.2 Global Droxidopa Forecasted Sales by Application (2022-2027)
6.1.3 Global Droxidopa Sales Market Share by Application (2016-2027)
6.2 Global Droxidopa Revenue by Application
6.2.1 Global Droxidopa Historical Revenue by Application (2016-2021)
6.2.2 Global Droxidopa Forecasted Revenue by Application (2022-2027)
6.2.3 Global Droxidopa Revenue Market Share by Application (2016-2027)
6.3 Global Droxidopa Price by Application
6.3.1 Global Droxidopa Price by Application (2016-2021)
6.3.2 Global Droxidopa Price Forecast by Application (2022-2027)
7 North America
7.1 North America Droxidopa Market Size by Type
7.1.1 North America Droxidopa Sales by Type (2016-2027)
7.1.2 North America Droxidopa Revenue by Type (2016-2027)
7.2 North America Droxidopa Market Size by Application
7.2.1 North America Droxidopa Sales by Application (2016-2027)
7.2.2 North America Droxidopa Revenue by Application (2016-2027)
7.3 North America Droxidopa Sales by Country
7.3.1 North America Droxidopa Sales by Country (2016-2027)
7.3.2 North America Droxidopa Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Droxidopa Market Size by Type
8.1.1 Europe Droxidopa Sales by Type (2016-2027)
8.1.2 Europe Droxidopa Revenue by Type (2016-2027)
8.2 Europe Droxidopa Market Size by Application
8.2.1 Europe Droxidopa Sales by Application (2016-2027)
8.2.2 Europe Droxidopa Revenue by Application (2016-2027)
8.3 Europe Droxidopa Sales by Country
8.3.1 Europe Droxidopa Sales by Country (2016-2027)
8.3.2 Europe Droxidopa Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Droxidopa Market Size by Type
9.1.1 Asia Pacific Droxidopa Sales by Type (2016-2027)
9.1.2 Asia Pacific Droxidopa Revenue by Type (2016-2027)
9.2 Asia Pacific Droxidopa Market Size by Application
9.2.1 Asia Pacific Droxidopa Sales by Application (2016-2027)
9.2.2 Asia Pacific Droxidopa Revenue by Application (2016-2027)
9.3 Asia Pacific Droxidopa Sales by Region
9.3.1 Asia Pacific Droxidopa Sales by Region (2016-2027)
9.3.2 Asia Pacific Droxidopa Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Droxidopa Market Size by Type
10.1.1 Latin America Droxidopa Sales by Type (2016-2027)
10.1.2 Latin America Droxidopa Revenue by Type (2016-2027)
10.2 Latin America Droxidopa Market Size by Application
10.2.1 Latin America Droxidopa Sales by Application (2016-2027)
10.2.2 Latin America Droxidopa Revenue by Application (2016-2027)
10.3 Latin America Droxidopa Sales by Country
10.3.1 Latin America Droxidopa Sales by Country (2016-2027)
10.3.2 Latin America Droxidopa Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Droxidopa Market Size by Type
11.1.1 Middle East and Africa Droxidopa Sales by Type (2016-2027)
11.1.2 Middle East and Africa Droxidopa Revenue by Type (2016-2027)
11.2 Middle East and Africa Droxidopa Market Size by Application
11.2.1 Middle East and Africa Droxidopa Sales by Application (2016-2027)
11.2.2 Middle East and Africa Droxidopa Revenue by Application (2016-2027)
11.3 Middle East and Africa Droxidopa Sales by Country
11.3.1 Middle East and Africa Droxidopa Sales by Country (2016-2027)
11.3.2 Middle East and Africa Droxidopa Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Piramal Enterprises Limited
12.1.1 Piramal Enterprises Limited Corporation Information
12.1.2 Piramal Enterprises Limited Overview
12.1.3 Piramal Enterprises Limited Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Piramal Enterprises Limited Droxidopa Product Description
12.1.5 Piramal Enterprises Limited Recent Developments
12.2 Lupin Ltd
12.2.1 Lupin Ltd Corporation Information
12.2.2 Lupin Ltd Overview
12.2.3 Lupin Ltd Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Lupin Ltd Droxidopa Product Description
12.2.5 Lupin Ltd Recent Developments
12.3 Sun Pharmaceutical Industries Ltd.
12.3.1 Sun Pharmaceutical Industries Ltd. Corporation Information
12.3.2 Sun Pharmaceutical Industries Ltd. Overview
12.3.3 Sun Pharmaceutical Industries Ltd. Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Industries Ltd. Droxidopa Product Description
12.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments
12.4 Clarochem Ireland
12.4.1 Clarochem Ireland Corporation Information
12.4.2 Clarochem Ireland Overview
12.4.3 Clarochem Ireland Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Clarochem Ireland Droxidopa Product Description
12.4.5 Clarochem Ireland Recent Developments
12.5 Estechpharma Co., Ltd.
12.5.1 Estechpharma Co., Ltd. Corporation Information
12.5.2 Estechpharma Co., Ltd. Overview
12.5.3 Estechpharma Co., Ltd. Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Estechpharma Co., Ltd. Droxidopa Product Description
12.5.5 Estechpharma Co., Ltd. Recent Developments
12.6 Chongqing Shenghuaxi Pharm Co.,Ltd.
12.6.1 Chongqing Shenghuaxi Pharm Co.,Ltd. Corporation Information
12.6.2 Chongqing Shenghuaxi Pharm Co.,Ltd. Overview
12.6.3 Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Product Description
12.6.5 Chongqing Shenghuaxi Pharm Co.,Ltd. Recent Developments
12.7 JINLAN Pharm-Drugs Technology Co., Ltd.
12.7.1 JINLAN Pharm-Drugs Technology Co., Ltd. Corporation Information
12.7.2 JINLAN Pharm-Drugs Technology Co., Ltd. Overview
12.7.3 JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Product Description
12.7.5 JINLAN Pharm-Drugs Technology Co., Ltd. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Droxidopa Industry Chain Analysis
13.2 Droxidopa Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Droxidopa Production Mode & Process
13.4 Droxidopa Sales and Marketing
13.4.1 Droxidopa Sales Channels
13.4.2 Droxidopa Distributors
13.5 Droxidopa Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Droxidopa Industry Trends
14.2 Droxidopa Market Drivers
14.3 Droxidopa Market Challenges
14.4 Droxidopa Market Restraints
15 Key Finding in The Global Droxidopa Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Droxidopa Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Droxidopa Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Droxidopa Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Droxidopa Production by Region (2016-2021) & (Ton)
Table 7. Global Droxidopa Production Market Share by Region (2016-2021)
Table 8. Global Droxidopa Production by Region (2022-2027) & (Ton)
Table 9. Global Droxidopa Production Market Share by Region (2022-2027)
Table 10. Global Droxidopa Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Droxidopa Sales by Region (2016-2021) & (Ton)
Table 12. Global Droxidopa Sales Market Share by Region (2016-2021)
Table 13. Global Droxidopa Sales by Region (2022-2027) & (Ton)
Table 14. Global Droxidopa Sales Market Share by Region (2022-2027)
Table 15. Global Droxidopa Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Droxidopa Revenue Market Share by Region (2016-2021)
Table 17. Global Droxidopa Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Droxidopa Revenue Market Share by Region (2022-2027)
Table 19. Global Droxidopa Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Droxidopa Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Droxidopa Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Droxidopa Production Market Share by Manufacturers (2016-2021)
Table 23. Global Droxidopa Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Droxidopa Sales Share by Manufacturers (2016-2021)
Table 25. Global Droxidopa Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Droxidopa Revenue Share by Manufacturers (2016-2021)
Table 27. Droxidopa Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Droxidopa Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Droxidopa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Droxidopa as of 2020)
Table 30. Droxidopa Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Droxidopa Product Offered
Table 32. Date of Manufacturers Enter into Droxidopa Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Droxidopa Sales by Type (2016-2021) & (Ton)
Table 35. Global Droxidopa Sales by Type (2022-2027) & (Ton)
Table 36. Global Droxidopa Sales Share by Type (2016-2021)
Table 37. Global Droxidopa Sales Share by Type (2022-2027)
Table 38. Global Droxidopa Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Droxidopa Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Droxidopa Revenue Share by Type (2016-2021)
Table 41. Global Droxidopa Revenue Share by Type (2022-2027)
Table 42. Droxidopa Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Droxidopa Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Droxidopa Sales by Application (2016-2021) & (Ton)
Table 45. Global Droxidopa Sales by Application (2022-2027) & (Ton)
Table 46. Global Droxidopa Sales Share by Application (2016-2021)
Table 47. Global Droxidopa Sales Share by Application (2022-2027)
Table 48. Global Droxidopa Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Droxidopa Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Droxidopa Revenue Share by Application (2016-2021)
Table 51. Global Droxidopa Revenue Share by Application (2022-2027)
Table 52. Droxidopa Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Droxidopa Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Droxidopa Sales by Type (2016-2021) & (Ton)
Table 55. North America Droxidopa Sales by Type (2022-2027) & (Ton)
Table 56. North America Droxidopa Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Droxidopa Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Droxidopa Sales by Application (2016-2021) & (Ton)
Table 59. North America Droxidopa Sales by Application (2022-2027) & (Ton)
Table 60. North America Droxidopa Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Droxidopa Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Droxidopa Sales by Country (2016-2021) & (Ton)
Table 63. North America Droxidopa Sales by Country (2022-2027) & (Ton)
Table 64. North America Droxidopa Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Droxidopa Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Droxidopa Sales by Type (2016-2021) & (Ton)
Table 67. Europe Droxidopa Sales by Type (2022-2027) & (Ton)
Table 68. Europe Droxidopa Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Droxidopa Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Droxidopa Sales by Application (2016-2021) & (Ton)
Table 71. Europe Droxidopa Sales by Application (2022-2027) & (Ton)
Table 72. Europe Droxidopa Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Droxidopa Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Droxidopa Sales by Country (2016-2021) & (Ton)
Table 75. Europe Droxidopa Sales by Country (2022-2027) & (Ton)
Table 76. Europe Droxidopa Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Droxidopa Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Droxidopa Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Droxidopa Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Droxidopa Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Droxidopa Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Droxidopa Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Droxidopa Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Droxidopa Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Droxidopa Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Droxidopa Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Droxidopa Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Droxidopa Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Droxidopa Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Droxidopa Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Droxidopa Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Droxidopa Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Droxidopa Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Droxidopa Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Droxidopa Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Droxidopa Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Droxidopa Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Droxidopa Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Droxidopa Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Droxidopa Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Droxidopa Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Droxidopa Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Droxidopa Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Droxidopa Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Droxidopa Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Droxidopa Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Droxidopa Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Droxidopa Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Droxidopa Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Droxidopa Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Droxidopa Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Droxidopa Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Droxidopa Revenue by Country (2022-2027) & (US$ Million)
Table 114. Piramal Enterprises Limited Corporation Information
Table 115. Piramal Enterprises Limited Description and Major Businesses
Table 116. Piramal Enterprises Limited Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Piramal Enterprises Limited Droxidopa Product
Table 118. Piramal Enterprises Limited Recent Development
Table 119. Lupin Ltd Corporation Information
Table 120. Lupin Ltd Description and Major Businesses
Table 121. Lupin Ltd Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Lupin Ltd Droxidopa Product
Table 123. Lupin Ltd Recent Development
Table 124. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 125. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 126. Sun Pharmaceutical Industries Ltd. Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Sun Pharmaceutical Industries Ltd. Droxidopa Product
Table 128. Sun Pharmaceutical Industries Ltd. Recent Development
Table 129. Clarochem Ireland Corporation Information
Table 130. Clarochem Ireland Description and Major Businesses
Table 131. Clarochem Ireland Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Clarochem Ireland Droxidopa Product
Table 133. Clarochem Ireland Recent Development
Table 134. Estechpharma Co., Ltd. Corporation Information
Table 135. Estechpharma Co., Ltd. Description and Major Businesses
Table 136. Estechpharma Co., Ltd. Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Estechpharma Co., Ltd. Droxidopa Product
Table 138. Estechpharma Co., Ltd. Recent Development
Table 139. Chongqing Shenghuaxi Pharm Co.,Ltd. Corporation Information
Table 140. Chongqing Shenghuaxi Pharm Co.,Ltd. Description and Major Businesses
Table 141. Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Product
Table 143. Chongqing Shenghuaxi Pharm Co.,Ltd. Recent Development
Table 144. JINLAN Pharm-Drugs Technology Co., Ltd. Corporation Information
Table 145. JINLAN Pharm-Drugs Technology Co., Ltd. Description and Major Businesses
Table 146. JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Product
Table 148. JINLAN Pharm-Drugs Technology Co., Ltd. Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Droxidopa Distributors List
Table 152. Droxidopa Customers List
Table 153. Droxidopa Market Trends
Table 154. Droxidopa Market Drivers
Table 155. Droxidopa Market Challenges
Table 156. Droxidopa Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Droxidopa Product Picture
Figure 2. Global Droxidopa Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Droxidopa Market Share by Application in 2020 & 2027
Figure 6. Droxidopa Tablets
Figure 7. Droxidopa Capsules
Figure 8. Others
Figure 9. Droxidopa Report Years Considered
Figure 10. Global Droxidopa Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 11. Global Droxidopa Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 12. Global Droxidopa Production Market Share by Region (2016-2021)
Figure 13. Global Droxidopa Production Market Share by Region (2022-2027)
Figure 14. Droxidopa Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Droxidopa Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Droxidopa Production Growth Rate in India (2016-2027) & (Ton)
Figure 17. Droxidopa Production Growth Rate in South Korea (2016-2027) & (Ton)
Figure 18. Global Droxidopa Sales 2016-2027 (Ton)
Figure 19. Global Droxidopa Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Droxidopa Revenue 2016-2027 (US$ Million)
Figure 21. Global Droxidopa Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 22. Global Droxidopa Sales Market Share by Region (2016-2021)
Figure 23. Global Droxidopa Sales Market Share by Region (2022-2027)
Figure 24. North America Droxidopa Sales YoY (2016-2027) & (Ton)
Figure 25. North America Droxidopa Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Europe Droxidopa Sales YoY (2016-2027) & (Ton)
Figure 27. Europe Droxidopa Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Asia-Pacific Droxidopa Sales YoY (2016-2027) & (Ton)
Figure 29. Asia-Pacific Droxidopa Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Latin America Droxidopa Sales YoY (2016-2027) & (Ton)
Figure 31. Latin America Droxidopa Revenue YoY (2016-2027) & (US$ Million)
Figure 32. Middle East & Africa Droxidopa Sales YoY (2016-2027) & (Ton)
Figure 33. Middle East & Africa Droxidopa Revenue YoY (2016-2027) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Droxidopa Sales in 2020
Figure 35. The Top 10 and Top 5 Players Market Share by Droxidopa Revenue in 2020
Figure 36. Droxidopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 37. Global Droxidopa Sales Market Share by Type (2016-2027)
Figure 38. Global Droxidopa Revenue Market Share by Type (2016-2027)
Figure 39. Global Droxidopa Sales Market Share by Application (2016-2027)
Figure 40. Global Droxidopa Revenue Market Share by Application (2016-2027)
Figure 41. North America Droxidopa Sales Market Share by Type (2016-2027)
Figure 42. North America Droxidopa Revenue Market Share by Type (2016-2027)
Figure 43. North America Droxidopa Sales Market Share by Application (2016-2027)
Figure 44. North America Droxidopa Revenue Market Share by Application (2016-2027)
Figure 45. North America Droxidopa Sales Share by Country (2016-2027)
Figure 46. North America Droxidopa Revenue Share by Country (2016-2027)
Figure 47. United States Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 48. Canada Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 49. Europe Droxidopa Sales Market Share by Type (2016-2027)
Figure 50. Europe Droxidopa Revenue Market Share by Type (2016-2027)
Figure 51. Europe Droxidopa Sales Market Share by Application (2016-2027)
Figure 52. Europe Droxidopa Revenue Market Share by Application (2016-2027)
Figure 53. Europe Droxidopa Sales Share by Country (2016-2027)
Figure 54. Europe Droxidopa Revenue Share by Country (2016-2027)
Figure 55. Germany Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 56. France Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 57. U.K. Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 58. Italy Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 59. Russia Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 60. Asia Pacific Droxidopa Sales Market Share by Type (2016-2027)
Figure 61. Asia Pacific Droxidopa Revenue Market Share by Type (2016-2027)
Figure 62. Asia Pacific Droxidopa Sales Market Share by Application (2016-2027)
Figure 63. Asia Pacific Droxidopa Revenue Market Share by Application (2016-2027)
Figure 64. Asia Pacific Droxidopa Sales Share by Region (2016-2027)
Figure 65. Asia Pacific Droxidopa Revenue Share by Region (2016-2027)
Figure 66. China Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 67. Japan Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 68. South Korea Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 69. India Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 70. Australia Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 71. China Taiwan Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 72. Indonesia Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 73. Thailand Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 74. Malaysia Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 75. Latin America Droxidopa Sales Market Share by Type (2016-2027)
Figure 76. Latin America Droxidopa Revenue Market Share by Type (2016-2027)
Figure 77. Latin America Droxidopa Sales Market Share by Application (2016-2027)
Figure 78. Latin America Droxidopa Revenue Market Share by Application (2016-2027)
Figure 79. Latin America Droxidopa Sales Share by Country (2016-2027)
Figure 80. Latin America Droxidopa Revenue Share by Country (2016-2027)
Figure 81. Mexico Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 82. Brazil Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 83. Argentina Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 84. Middle East and Africa Droxidopa Sales Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Droxidopa Revenue Market Share by Type (2016-2027)
Figure 86. Middle East and Africa Droxidopa Sales Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Droxidopa Revenue Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Droxidopa Sales Share by Country (2016-2027)
Figure 89. Middle East and Africa Droxidopa Revenue Share by Country (2016-2027)
Figure 90. Turkey Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 91. Saudi Arabia Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 92. UAE Droxidopa Revenue (2016-2027) & (US$ Million)
Figure 93. Droxidopa Value Chain
Figure 94. Droxidopa Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
世界の高純度1,4-ジオキサン市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity 1,4-Dioxane Market The global High Purity 1,4-Dioxane market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity 1,4-Dioxane Scope and Segment…- 世界の高純度1,4-ジオキサン市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity 1,4-Dioxane Market The global High Purity 1,4-Dioxane market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity 1,4-Dioxane Scope and Segment…
- 世界の高純度メントール市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity Menthol Market The global High Purity Menthol market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity Menthol Scope and Segment High Purity…
- 世界の高純度2-メルカプトエタノール市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity 2-Mercaptoethanol Market The global High Purity 2-Mercaptoethanol market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity 2-Mercaptoethanol…
- 世界の高純度2-メルカプトエタノール市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity 2-Mercaptoethanol Market The global High Purity 2-Mercaptoethanol market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity 2-Mercaptoethanol…